Susquehanna Portfolio Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.1M Sell
29,264
-300
-1% -$307K 0.56% 41
2026
Q1
$27.2M Hold
29,564
– – 0.4% 63
2025
Q4
$31.8M Hold
29,564
– – 0.49% 47
2025
Q3
$22.6M Buy
29,564
+20,867
+240% +$15.5M 0.36% 70
2025
Q2
$6.78M Buy
+8,697
New +$6.76M 0.15% 188
2024
Q2
– Sell
-5,785
Closed -$4.5M – 651
2024
Q1
$4.5M Sell
5,785
-25,383
-81% -$18.1M 0.1% 229
2023
Q4
$18.2M Buy
+31,168
New +$18.2M 0.32% 87

Other funds holding LLY

Susquehanna Portfolio Strategies's LLY Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $307K and leaving 29,264 shares worth $35.1M. The position accounts for 0.56% of the portfolio, ranked #41.

Susquehanna Portfolio Strategies first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 4,647 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Susquehanna Portfolio Strategies held 29,264 shares of Eli Lilly worth $35.1M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 300 Eli Lilly shares in Q2 2026, an estimated $307K.
  • Eli Lilly made up 0.56% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #41 holding.
  • Susquehanna Portfolio Strategies first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
  • 4,647 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.